A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.
One of the biggest challenges in the field of public health, especially in the case of asymptomatic chronic diseases such as hypertension, diabetes and dyslipidemia, is poor adherence, i.e. non-compliance with the prescribed treatment plan, whether it is about taking medication or adopting healthy lifestyle habits.